Concepedia
Statistics
Publications
13
Citations
596
H-Index
12
Active since
2017
Affiliations
Dana-Farber Cancer Institute(Current)
Duke University
Duke Medical Center
Harvard University
China Medical University
Yinglu Zhou is an author at Dana-Farber Cancer Institute specializing in oncology, medicine, and molecular oncology.
Publications per year
2017–2025
Ectopic JAK–STAT activation enables the transition to a stem-like and multilineage state conferring AR-targeted therapy resistance
Su Deng, Choushi Wang, Yunguan Wang et al. · Nature Cancer · 2022 · 149 citations · Full text
Medicine, Molecular Biology, Oncology +17
Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancer
Yanjing Li, Yiping He, William Butler et al. · Science Translational Medicine · 2019 · 136 citations · Full text
Medicine, Cell Biology, Oncology +17
Pirtobrutinib targets BTK C481S in ibrutinib-resistant CLL but second-site BTK mutations lead to resistance
Aishath Naeem, Filippo Utro, Qing Wang et al. · Blood Advances · 2022 · 79 citations · Full text
Medicine, Oncology, Pharmacology +14
Cytotoxic and chemosensitization effects of Scutellarin from traditional Chinese herb Scutellaria altissima L. in human prostate cancer cells
Chen Gao, Yinglu Zhou, Zhongling Jiang et al. · Oncology Reports · 2017 · 58 citations · Full text
Medicine, Oncology, Pharmacology +13
Antitumor effects of baicalin on ovarian cancer cells through induction of cell apoptosis and inhibition of cell migration in vitro
Chen Gao, Yinglu Zhou, Huatao Li et al. · Molecular Medicine Reports · 2017 · 50 citations · Full text
1–5 of 13